191 related articles for article (PubMed ID: 28629242)
1. Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro.
Singh RK; Diwan M; Dastidar SG; Najmi AK
Hum Exp Toxicol; 2018 May; 37(5):521-531. PubMed ID: 28629242
[TBL] [Abstract][Full Text] [Related]
2. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR
J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073
[TBL] [Abstract][Full Text] [Related]
3. p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes.
Dulos J; Wijnands FP; van den Hurk-van Alebeek JA; van Vugt MJ; Rullmann JA; Schot JJ; de Groot MW; Wagenaars JL; van Ravestein-van Os R; Smets RL; Vink PM; Hofstra CL; Nelissen RL; van Eenennaam H
Clin Exp Rheumatol; 2013; 31(4):515-25. PubMed ID: 23558031
[TBL] [Abstract][Full Text] [Related]
4. Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders.
Singh RK; Najmi AK
Curr Drug Targets; 2019; 20(4):367-379. PubMed ID: 30112991
[TBL] [Abstract][Full Text] [Related]
5. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
6. Biological functions and role of mitogen-activated protein kinase activated protein kinase 2 (MK2) in inflammatory diseases.
Singh RK; Najmi AK; Dastidar SG
Pharmacol Rep; 2017 Aug; 69(4):746-756. PubMed ID: 28582691
[TBL] [Abstract][Full Text] [Related]
7. The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis.
Soukup K; Halfmann A; Le Bras M; Sahin E; Vittori S; Poyer F; Schuh C; Luger R; Niederreiter B; Haider T; Stoiber D; Blüml S; Schabbauer G; Kotlyarov A; Gaestel M; Felzmann T; Dohnal AM
J Immunol; 2015 Jul; 195(2):541-52. PubMed ID: 26078274
[TBL] [Abstract][Full Text] [Related]
8. Regulation of monocyte subset proinflammatory responses within the lung microvasculature by the p38 MAPK/MK2 pathway.
O'Dea KP; Dokpesi JO; Tatham KC; Wilson MR; Takata M
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L812-21. PubMed ID: 21873449
[TBL] [Abstract][Full Text] [Related]
9. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.
Coxon PY; Rane MJ; Uriarte S; Powell DW; Singh S; Butt W; Chen Q; McLeish KR
Cell Signal; 2003 Nov; 15(11):993-1001. PubMed ID: 14499342
[TBL] [Abstract][Full Text] [Related]
10. MK2: a novel molecular target for anti-inflammatory therapy.
Duraisamy S; Bajpai M; Bughani U; Dastidar SG; Ray A; Chopra P
Expert Opin Ther Targets; 2008 Aug; 12(8):921-36. PubMed ID: 18620516
[TBL] [Abstract][Full Text] [Related]
11. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
[TBL] [Abstract][Full Text] [Related]
12. CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production.
Gaur R; Mensah KA; Stricker J; Adams M; Parton A; Cedzik D; Connarn J; Thomas M; Horan G; Schafer P; Mair S; Palmisano M; Ramírez-Valle F
Arthritis Res Ther; 2022 Aug; 24(1):199. PubMed ID: 35982464
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signaling.
Gruenbaum LM; Schwartz R; Woska JR; DeLeon RP; Peet GW; Warren TC; Capolino A; Mara L; Morelock MM; Shrutkowski A; Jones JW; Pargellis CA
Biochem Pharmacol; 2009 Feb; 77(3):422-32. PubMed ID: 19027720
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.
Nie X; Chanley MA; Pengal R; Thomas DB; Agrawal S; Smoyer WE
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F602-F613. PubMed ID: 29187369
[TBL] [Abstract][Full Text] [Related]
15. IL-1β-induced and p38
Kulawik A; Engesser R; Ehlting C; Raue A; Albrecht U; Hahn B; Lehmann WD; Gaestel M; Klingmüller U; Häussinger D; Timmer J; Bode JG
J Biol Chem; 2017 Apr; 292(15):6291-6302. PubMed ID: 28223354
[TBL] [Abstract][Full Text] [Related]
16. An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation Inhibitors.
Hedström U; Norberg M; Evertsson E; Lever SR; Munck Af Rosenschöld M; Lönn H; Bold P; Käck H; Berntsson P; Vinblad J; Liu J; Welinder A; Karlsson J; Snijder A; Pardali K; Andersson U; Davis AM; Mogemark M
ChemMedChem; 2019 Oct; 14(19):1701-1709. PubMed ID: 31325352
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2.
Alimbetov D; Davis T; Brook AJ; Cox LS; Faragher RG; Nurgozhin T; Zhumadilov Z; Kipling D
Biogerontology; 2016 Apr; 17(2):305-15. PubMed ID: 26400758
[TBL] [Abstract][Full Text] [Related]
18. MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation.
Bobo LD; El Feghaly RE; Chen YS; Dubberke ER; Han Z; Baker AH; Li J; Burnham CA; Haslam DB
Infect Immun; 2013 Mar; 81(3):713-22. PubMed ID: 23264053
[TBL] [Abstract][Full Text] [Related]
19. p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells.
Petrova T; Pesic J; Pardali K; Gaestel M; Arthur JSC
Sci Rep; 2020 Feb; 10(1):3479. PubMed ID: 32103032
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor.
Terajima M; Inoue T; Magari K; Yamazaki H; Higashi Y; Mizuhara H
Eur J Pharmacol; 2013 Jan; 698(1-3):455-62. PubMed ID: 23183108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
